41 related articles for article (PubMed ID: 14508837)
1. The bottleneck effect in lung cancer clinical trials.
Gonzalez LE; Sutton SK; Pratt C; Gilbertson M; Antonia S; Quinn GP
J Cancer Educ; 2013 Sep; 28(3):488-93. PubMed ID: 23733149
[TBL] [Abstract][Full Text] [Related]
2. "Factors associated with non-small cell lung cancer treatment costs in a Brazilian public hospital".
de Barros Reis C; Knust RE; de Aguiar Pereira CC; Portela MC
BMC Health Serv Res; 2018 Feb; 18(1):124. PubMed ID: 29454338
[TBL] [Abstract][Full Text] [Related]
3. Effort required in eligibility screening for clinical trials.
Penberthy LT; Dahman BA; Petkov VI; DeShazo JP
J Oncol Pract; 2012 Nov; 8(6):365-70. PubMed ID: 23598846
[TBL] [Abstract][Full Text] [Related]
4. Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.
van Asselt T; Ramaekers B; Corro Ramos I; Joore M; Al M; Lesman-Leegte I; Postma M; Vemer P; Feenstra T
Pharmacoeconomics; 2018 Jan; 36(1):105-113. PubMed ID: 28933003
[TBL] [Abstract][Full Text] [Related]
5. Factors contributing to economic burden in lung cancer spousal caregivers.
Kavanaugh M; Kramer BJ; Walsh MC; Trentham-Dietz A
Palliat Support Care; 2015 Jun; 13(3):691-700. PubMed ID: 24825661
[TBL] [Abstract][Full Text] [Related]
6. Economics of treatments for non-small cell lung cancer.
Chouaid C; Atsou K; Hejblum G; Vergnenegre A
Pharmacoeconomics; 2009; 27(2):113-25. PubMed ID: 19254045
[TBL] [Abstract][Full Text] [Related]
7. An educational video to increase clinical trials enrollment among breast cancer patients.
Du W; Mood D; Gadgeel S; Simon MS
Breast Cancer Res Treat; 2009 Sep; 117(2):339-47. PubMed ID: 19152024
[TBL] [Abstract][Full Text] [Related]
8. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness and lung cancer clinical trials.
Du W; Reeves JH; Gadgeel S; Abrams J; Peters WP
Cancer; 2003 Oct; 98(7):1491-6. PubMed ID: 14508837
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
Spiro SG; Rudd RM; Souhami RL; Brown J; Fairlamb DJ; Gower NH; Maslove L; Milroy R; Napp V; Parmar MK; Peake MD; Stephens RJ; Thorpe H; Waller DA; West P;
Thorax; 2004 Oct; 59(10):828-36. PubMed ID: 15454647
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.
Ng R; Hasan B; Mittmann N; Florescu M; Shepherd FA; Ding K; Butts CA; Cormier Y; Darling G; Goss GD; Inculet R; Seymour L; Winton TL; Evans WK; Leighl NB; ; ;
J Clin Oncol; 2007 Jun; 25(16):2256-61. PubMed ID: 17538170
[TBL] [Abstract][Full Text] [Related]
14. Predictors of enrollment in lung cancer clinical trials.
Du W; Gadgeel SM; Simon MS
Cancer; 2006 Jan; 106(2):420-5. PubMed ID: 16342295
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
